Cargando…

Cost-effectiveness of Colorectal Cancer Screening

Colorectal cancer is an important public health problem. Several screening methods have been shown to be effective in reducing colorectal cancer mortality. The objective of this review was to assess the cost-effectiveness of the different colorectal cancer screening methods and to determine the pref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lansdorp-Vogelaar, Iris, Knudsen, Amy B., Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132805/ https://www.ncbi.nlm.nih.gov/pubmed/21633092 http://dx.doi.org/10.1093/epirev/mxr004

Ejemplares similares

Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
por: Peterse, Elisabeth F P, et al.
Publicado: (2020)

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
por: Naber, Steffie K., et al.
Publicado: (2019)

Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors
por: Gini, Andrea, et al.
Publicado: (2019)

Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia
por: Naber, Steffie K., et al.
Publicado: (2021)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study
por: Wang, Jie, et al.
Publicado: (2022)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
por: Cenin, Dayna R, et al.
Publicado: (2018)

Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline
por: Meester, Reinier G. S., et al.
Publicado: (2018)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
por: van Duuren, Luuk A., et al.
Publicado: (2022)

Optimising colorectal cancer screening in Shanghai, China: a modelling study
por: Cenin, Dayna, et al.
Publicado: (2022)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands
por: de Klerk, Clasine M., et al.
Publicado: (2022)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration
por: Omidvari, Amir-Houshang, et al.
Publicado: (2021)

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2022)

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential
por: Naber, Steffie K, et al.
Publicado: (2019)

Personalised colorectal cancer screening strategies: Information needs of the target population
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data
por: Preen, David B., et al.
Publicado: (2017)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model
por: Arrospide, Arantzazu, et al.
Publicado: (2018)

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
por: Buskermolen, Maaike, et al.
Publicado: (2019)

Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study
por: Alblas, Maaike, et al.
Publicado: (2021)

The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline
por: Peterse, Elisabeth F. P., et al.
Publicado: (2018)

Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic
por: Nascimento de Lima, Pedro, et al.
Publicado: (2023)

Emulator-based Bayesian calibration of the CISNET colorectal cancer models
por: Pineda-Antunez, Carlos, et al.
Publicado: (2023)

Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
por: Meester, Reinier G S, et al.
Publicado: (2015)

Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?
por: McFerran, Ethna, et al.
Publicado: (2022)

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic
por: Kortlever, Tim L., et al.
Publicado: (2021)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis
por: van den Puttelaar, Rosita, et al.
Publicado: (2023)

652: IMPACT AND RECOVERY FROM COVID-19-RELATED DISRUPTIONS IN COLORECTAL CANCER SCREENING AND CARE: A SCENARIO ANALYSIS
por: Puttelaar, Rosita van den, et al.
Publicado: (2022)

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis
por: de Lima, Pedro Nascimento, et al.
Publicado: (2022)

Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
por: Breekveldt, Emilie C. H., et al.
Publicado: (2023)

Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled Trial
por: Plys, Ekaterina, et al.
Publicado: (2023)

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
por: Worthington, Joachim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18os7q40b2a01gf4mqs1e2aaes